Published on 29 May 2024 on Market Watch
Merck to buy EyeBio in a deal that could valued at up to $3 billion
announced Wednesday an agreement to buy privately held Eyebiotech Ltd., an ophthalmology-focused...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free